SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-016490
Filing Date
2018-03-12
Accepted
2018-03-12 08:00:41
Documents
12
Period of Report
2018-03-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-7974_18k.htm 8-K 26209
2 EX-10.1 a18-7974_1ex10d1.htm EX-10.1 1366697
3 GRAPHIC g79741ki27ai001.jpg GRAPHIC 57648
4 GRAPHIC g79741ki17ai001.jpg GRAPHIC 48017
5 GRAPHIC g79741ki19i001.jpg GRAPHIC 58802
6 GRAPHIC g79741ki35i001.jpg GRAPHIC 55293
7 GRAPHIC g79741ki35i002.jpg GRAPHIC 36748
8 GRAPHIC g79741ki35i003.jpg GRAPHIC 46565
9 GRAPHIC g79741ki35i004.jpg GRAPHIC 44664
10 GRAPHIC g79741ki21i001.jpg GRAPHIC 25623
11 GRAPHIC g79741ki27i001.jpg GRAPHIC 45668
12 GRAPHIC g79741ki17i001.gif GRAPHIC 35378
  Complete submission text file 0001104659-18-016490.txt   2021323
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38150 | Film No.: 18682090
SIC: 2834 Pharmaceutical Preparations